Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-06

Clinical Trial Update: Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the safety and efficacy of combining belimumab with voclosporin for proliferative lupus nephritis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BENLYSTA (belimumab)
  • LUPKYNIS (voclosporin)

Snippet

Sponsor: NephroNet, Inc. | Conditions: Lupus Nephritis | Phase 4 | Status: RECRUITING